Hikma Announces Expanded Licensing Agreement with Takeda for New Products in...

Mundipharma Highlights the Need to Commit to Innovating and Developing Pioneering...

Boehringer Ingelheim Recognized As Global Top Employer for 2021

Julphar announces robust Q2 2022 results marking a return to profitability

Hikma continues strong 2021 performance and reiterates full year guidance

Janssen EMEA Receives Conditional Marketing Authorisation for RYBREVANT® ▼ (amivantamab), the...

MSD Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational...

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of...

Breakthrough results for empagliflozin confirm EMPEROR-Preserved as first and only successful...

Mundipharma partners with Munir Sukhtian Group to strengthen its consumer healthcare...

123...7Page 1 of 7

Connect with us

1,840FansLike
243FollowersFollow
1,929FollowersFollow
30SubscribersSubscribe